MUCKLE-WELLS SYNDROME
Clinical trials for MUCKLE-WELLS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MUCKLE-WELLS SYNDROME trials appear
Sign up with your email to follow new studies for MUCKLE-WELLS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAPS pill enters first human tests
Disease control Recruiting nowThis early-phase trial is testing an experimental drug called JTE-162 in 5 adults with CAPS, a rare condition that causes fever, rash, and joint pain. Participants take one tablet daily for 2 weeks. Researchers will check if the drug safely reduces inflammation and improves sympt…
Matched conditions: MUCKLE-WELLS SYNDROME
Phase: PHASE1 • Sponsor: Akros Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New scan could reveal hidden organ damage without a biopsy
Diagnosis Recruiting nowThis study tests a radioactive tracer called 124I-AT-01 that binds to amyloid clumps in the body. Researchers want to see if PET/CT scans can detect amyloidosis in organs of people with CAPS who developed it from anakinra injections. Thirty adults will be scanned every 6 months f…
Matched conditions: MUCKLE-WELLS SYNDROME
Phase: PHASE1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Diagnosis
Last updated Jun 27, 2026 12:35 UTC
-
Could your body clock affect rare inflammatory disease?
Knowledge-focused Recruiting nowThis study looks at whether people with CAPS (a rare genetic inflammatory condition) have disrupted circadian rhythms—the body's natural day-night cycle. Researchers will measure melatonin levels and track activity with a watch in 30 participants (patients and healthy household m…
Matched conditions: MUCKLE-WELLS SYNDROME
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC